Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Cash from Financing Activities: 2020-2025

Historic Cash from Financing Activities for Cellebrite DI (CLBT) over the last 4 years, with Sep 2025 value amounting to $5.3 million.

  • Cellebrite DI's Cash from Financing Activities fell 4.72% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.4 million, marking a year-over-year increase of 59.57%. This contributed to the annual value of $20.7 million for FY2024, which is 5.12% down from last year.
  • Cellebrite DI's Cash from Financing Activities amounted to $5.3 million in Q3 2025, which was down 61.91% from $13.8 million recorded in Q2 2025.
  • Cellebrite DI's 5-year Cash from Financing Activities high stood at $13.8 million for Q2 2025, and its period low was -$69.5 million during Q3 2021.
  • In the last 3 years, Cellebrite DI's Cash from Financing Activities had a median value of $5.3 million in 2025 and averaged $5.9 million.
  • As far as peak fluctuations go, Cellebrite DI's Cash from Financing Activities soared by 436.70% in 2023, and later slumped by 41.57% in 2024.
  • Over the past 5 years, Cellebrite DI's Cash from Financing Activities (Quarterly) stood at $944,000 in 2021, then soared by 110.17% to $2.0 million in 2022, then soared by 128.33% to $4.5 million in 2023, then surged by 48.57% to $6.7 million in 2024, then dropped by 4.72% to $5.3 million in 2025.
  • Its last three reported values are $5.3 million in Q3 2025, $13.8 million for Q2 2025, and $3.6 million during Q1 2025.